Allergic Reactions

Oncology·MeSH: Hypersensitivity

9 drugs in development·5 companies·1 clinical trial

Drug Pipeline by Phase

Approved(5)

Drug	Company
diphenhydramine	ACHIEVE LIFE SCIENCES, INC. (ACHV)
diphenhydramine	Miromatrix Medical Inc. (MIRO)
nda	Aquestive Therapeutics, Inc. (AQST)
neffy (EURneffy in EU)	ARS Pharmaceuticals, Inc. (SPRY)
palforzia	Aimmune Therapeutics, Inc. (AIMT)

Phase 3(1)

Drug	Company
Anaphylm™	Aquestive Therapeutics, Inc. (AQST)

BLA Filed(1)

Drug	Company
anaphylm	Aquestive Therapeutics, Inc. (AQST)

Phase 4(2)

Drug	Company
adrenaline	ARS Pharmaceuticals, Inc. (SPRY)
neffy	ARS Pharmaceuticals, Inc. (SPRY)

BioSniper tracks 9 drugs in development for Allergic Reactions across 5 companies.

There are 1 clinical trial targeting Allergic Reactions tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.